Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00970541 · ClinicalTrials.gov registry record · Phase 1
Effect of Cinnamon Extract on Insulin Resistance in Polycystic Ovary Syndrome
A Phase 1 study, sponsored by Pennington Biomedical Research Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT00970541 is a Phase 1 study that was terminated before completion, run by Pennington Biomedical Research Center. The registered enrollment target is 8 participants.
The verdict
NCT00970541, a Phase 1 study, was terminated before completion, sponsored by Pennington Biomedical Research Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Cinnamon from the Cassae Plant is effective in the body as insulin could lower blood sugar levels.
Interventions
- DIETARY_SUPPLEMENT Cinnamon Supplementation
- DIETARY_SUPPLEMENT Placebo (wheat flour)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2009-08 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00970541
The ClinicalTrials.gov registry entry for NCT00970541 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cinnamon Supplementation is the first listed.
NCT00970541 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00970541 about?
NCT00970541 is a clinical study titled "Effect of Cinnamon Extract on Insulin Resistance in Polycystic Ovary Syndrome". The purpose of this study is to determine whether Cinnamon from the Cassae Plant is effective in the body as insulin could lower blood sugar levels.
What is the current status of trial NCT00970541?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2009-08. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00970541?
The interventions under investigation include: Cinnamon Supplementation (DIETARY_SUPPLEMENT), Placebo (wheat flour) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00970541?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.